請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10474
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李心予(Hsinyu Lee) | |
dc.contributor.author | Milky Shen-Yung Kao | en |
dc.contributor.author | 高笙詠 | zh_TW |
dc.date.accessioned | 2021-05-20T21:32:25Z | - |
dc.date.available | 2010-08-18 | |
dc.date.available | 2021-05-20T21:32:25Z | - |
dc.date.copyright | 2010-08-18 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-08-18 | |
dc.identifier.citation | 1. Shimizu T (2009) Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation. Annual Review of Pharmacology and Toxicology 49:123-150.
2. Lee HJ, Wall B, & Chen S (2008) G-protein-coupled receptors and melanoma. Pigment Cell & Melanoma Research 21(4):415-428. 3. Lagerstrom MC & Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery (vol 7, pg 339, 2008). Nature Reviews Drug Discovery 7(6):542-542. 4. Choi JW, et al. (2010) LPA Receptors: Subtypes and Biological Actions. Annual Review of Pharmacology and Toxicology 50:157-186. 5. Tanaka M, et al. (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. Journal of Biological Chemistry 281(35):25822-25830. 6. van Meeteren LA, et al. (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Molecular and Cellular Biology 26(13):5015-5022. 7. Hecht JH, Weiner JA, Post SR, & Chun J (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. Journal of Cell Biology 135(4):1071-1083. 8. Aoki J (2004) Mechanisms of lysophosphatidic acid production. Seminars in Cell & Developmental Biology 15(5):477-489. 9. Sugiura T, et al. (1999) Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids 1440(2-3):194-204. 10. Sano T, et al. (2002) Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. Journal of Biological Chemistry 277(24):21197-21206. 11. Murata J, et al. (1994) CDNA CLONING OF THE HUMAN TUMOR MOTILITY-STIMULATING PROTEIN, AUTOTAXIN, REVEALS A HOMOLOGY WITH PHOSPHODIESTERASES. Journal of Biological Chemistry 269(48):30479-30484. 12. Yang SY, et al. (2002) Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clinical & Experimental Metastasis 19(7):603-608. 13. Stassar M, et al. (2001) Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. British Journal of Cancer 85(9):1372-1382. 14. Baumforth KRN, et al. (2005) Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 106(6):2138-2146. 15. Zhang GX, Zhao ZQ, Xu SF, Ni L, & Wang XH (1999) Expression of autotaxin mRNA in human hepatocellular carcinoma. Chinese Medical Journal 112(4):330-332. 16. Kishi Y, et al. (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine TO lysophosphatidic acid. Journal of Biological Chemistry 281(25):17492-17500. 17. Stracke ML, et al. (1992) IDENTIFICATION, PURIFICATION, AND PARTIAL SEQUENCE-ANALYSIS OF AUTOTAXIN, A NOVEL MOTILITY-STIMULATING PROTEIN. Journal of Biological Chemistry 267(4):2524-2529. 34 18. Hiramatsu T, et al. (2003) Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A(1)s, mPA-PLA(1)alpha and mPA-PLA(1)beta. Journal of Biological Chemistry 278(49):49438-49447. 19. Sonoda H, et al. (2002) A novel phosphatidic acid-selective phospholipase A(1) that produces lysophosphatidic acid. Journal of Biological Chemistry 277(37):34254-34263. 20. Aoki J, Inoue A, Makide K, Saiki N, & Arai H (2007) Structure and function of extracellular phospholipase A(1) belonging to the pancreatic lipase gene family. Biochimie 89(2):197-204. 21. Ali G, Chishti MS, Raza SI, John P, & Ahmad W (2007) A mutation in the lipase H (LIPH) gene underlie autosomal recessive hypotrichosis. Human Genetics 121(3-4):319-325. 22. Kazantseva A, et al. (2006) Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Science 314(5801):982-985. 23. Pasternack SM, et al. (2008) G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nature Genetics 40(3):329-334. 24. Shimomura Y, et al. (2008) Disruption of the P2RY5 Gene, an orphan G-protein coupled receptor, underlies autosomal recessive woolly hair. Journal of Investigative Dermatology 128:875. 25. Contos JJA, Ishii I, & Chun J (2000) Lysophosphatidic acid receptors. Molecular Pharmacology 58(6):1188-1196. 26. Ye XQ (2008) Lysophospholipid signaling in the function and pathology of the reproductive system. Human Reproduction Update 14(5):519-536. 27. An SZ, Bleu T, Hallmark OG, & Goetzl EJ (1998) Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. Journal of Biological Chemistry 273(14):7906-7910. 28. Fukushima N, Kimura Y, & Chun J (1998) A single receptor encoded by vzg-1/lp(A1)/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proceedings of the National Academy of Sciences of the United States of America 95(11):6151-6156. 29. Ishii I, Contos JJA, Fukushima N, & Chun J (2000) Functional comparisons of the lysophosphatidic acid receptors, LP(A1)NVZG-1/EDG-2, LPA2/EDG-4, and LPA3/EDG-7 in neuronal cell lines using a retrovirus expression system. Molecular Pharmacology 58(5):895-902. 30. Contos JJA, Fukushima N, Weiner JA, Kaushal D, & Chun J (2000) Requirement for the Ip(A1) lysophosphatidic acid receptor gene in normal suckling behavior. Proceedings of the National Academy of Sciences of the United States of America 97(24):13384-13389. 31. Weiner JA, Fukushima N, Contos JJA, Scherer SS, & Chun J (2001) Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. Journal of Neuroscience 21(18):7069-7078. 32. Contos JJA & Chun J (2000) Genomic characterization of the lysophosphatidic acid receptor gene, Ip(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA. Genomics 64(2):155-169. 33. Deng WL, et al. (2002) Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis. Gastroenterology 123(1):206-216. 34. Goetzl EJ, Kong Y, & Mei BS (1999) Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. Journal of Immunology 162(4):2049-2056. 35. Panchatcharam M, et al. (2008) Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circulation Research 103(6):662-670. 35 36. Zheng YH, Kong Y, & Goetzl EJ (2001) Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane. Journal of Immunology 166(4):2317-2322. 37. Zheng YH, Voice JK, Kong Y, & Goetzl EJ (2000) Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. Faseb Journal 14(15):2387-2389. 38. Chen M, Towers LN, & O'Connor KL (2007) LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. American Journal of Physiology-Cell Physiology 292(5):C1927-C1933. 39. Yu SX, et al. (2008) Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells. Journal of the National Cancer Institute 100(22):1630-1642. 40. Lai YJ, Chen CS, Lin WC, & Lin FT (2005) c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Molecular and Cellular Biology 25(14):5859-5868. 41. Lai YJ, Lin WC, & Lin FT (2007) PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration. Journal of Biological Chemistry 282(33):24381-24387. 42. Lin FT & Lai YJ (2008) Regulation of the LPA(2) receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids 1781(9):558-562. 43. Komachi M, et al. (2009) LPA(1) receptors mediate stimulation, whereas LPA(2) receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis 30(3):457-465. 44. Bandoh K, et al. (1999) Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. Journal of Biological Chemistry 274(39):27776-27785. 45. Im DS, et al. (2000) Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Molecular Pharmacology 57(4):753-759. 46. Ye XQ, et al. (2005) LPA(3)-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435(7038):104-108. 47. Hama K, et al. (2006) Lysophosphatidic receptor, LPA(3), is positively and negatively regulated by progesterone and estrogen in the mouse uterus. Life Sciences 79(18):1736-1740. 48. Noguchi K, Ishii S, & Shimizu T (2003) Identification of p2y(9)/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. Journal of Biological Chemistry 278(28):25600-25606. 49. Lee CW, Rivera R, Dubin AE, & Chun J (2007) LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. Journal of Biological Chemistry 282(7):4310-4317. 50. Yanagida K, Ishii S, Hamano F, Noguchi K, & Shimizu T (2007) LPA(4)/p2y(9)/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line. Journal of Biological Chemistry 282(8):5814-5824. 51. Janssens R, Boeynaems JM, Godart M, & Communi D (1997) Cloning of a human heptahelical receptor closely related to the P2Y(5) receptor. Biochemical and Biophysical Research Communications 236(1):106-112. 52. Odowd BF, et al. (1997) Cloning and chromosomal mapping of four putative novel human G-protein-coupled receptor genes. Gene 187(1):75-81. 36 53. Lee Z, et al. (2008) Role of LPA(4)/p2y9/GPR23 in Negative Regulation of Cell Motility. Molecular Biology of the Cell 19(12):5435-5445. 54. Kotarsky K, et al. (2006) Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. Journal of Pharmacology and Experimental Therapeutics 318(2):619-628. 55. Lee CW, Rivera R, Gardell S, Dubin AE, & Chun J (2006) GPR92 as a new G(12/13)- and G(q)-coupled lysophosphatidic acid receptor that increases cAMP, LPA(5). Journal of Biological Chemistry 281(33):23589-23597. 56. Oh DY, et al. (2008) Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. Journal of Biological Chemistry 283(30):21054-21064. 57. Yin H, et al. (2009) Lipid G Protein-coupled Receptor Ligand Identification Using beta-Arrestin PathHunter (TM) Assay. Journal of Biological Chemistry 284(18):12328-12338. 58. Williams JR, et al. (2009) Unique Ligand Selectivity of the GPR92/LPA(5) Lysophosphatidate Receptor Indicates Role in Human Platelet Activation. Journal of Biological Chemistry 284(25):17304-17319. 59. Sen S, Smeby RR, & Bumpus FM (1968) ANTIHYPERTENSIVE EFFECT OF AN ISOLATED PHOSPHOLIPID. American Journal of Physiology 214(2):337-&. 60. Tokumura A, Fukuzawa K, & Tsukatani H (1978) EFFECTS OF SYNTHETIC AND NATURAL LYSOPHOSPHATIDIC ACIDS ON ARTERIAL BLOOD-PRESSURE OF DIFFERENT ANIMAL SPECIES. Lipids 13(8):572-574. 61. Anliker B & Chun J (2004) Cell surface receptors in lysophospholipid signaling. Seminars in Cell & Developmental Biology 15(5):457-465. 62. Choi JW, Lee CW, & Chun J (2008) Biological roles of lysophospholipid receptors revealed by genetic null mice: An update. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids 1781(9):531-539. 63. Estivill-Torrus G, et al. (2008) Absence of LPA(1) signaling results in defective cortical development. Cerebral Cortex 18(4):938-950. 64. Harrison SM, et al. (2003) LPA(1) receptor-deficient mice have phenotypic changes observed in psychiatric disease. Molecular and Cellular Neuroscience 24(4):1170-1179. 65. Kingsbury MA, Rehen SK, Contos JJA, Higgins CM, & Chun J (2003) Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nature Neuroscience 6(12):1292-1299. 66. Campbell DS & Holt CE (2001) Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32(6):1013-1026. 67. Fukushima N, Weiner JA, & Chun J (2000) Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Developmental Biology 228(1):6-18. 68. Yuan XB, et al. (2003) Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nature Cell Biology 5(1):38-45. 69. Fukushima N, et al. (2002) Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Molecular and Cellular Neuroscience 20(2):271-282. 70. Inoue M, et al. (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nature Medicine 10(7):712-718. 71. Inoue M, et al. (2008) Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 152(2):296-298. 72. Inoue M, Yamaguchi A, Kawakami M, Chun J, & Ueda H (2006) Loss of spinal substance P pain transmission under the condition of LPA(I) receptor-mediated neuropathic pain. Molecular Pain 2. 37 73. Contos JJA, et al. (2002) Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Molecular and Cellular Biology 22(19):6921-6929. 74. Rother E, et al. (2003) Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 108(6):741-747. 75. Pamuklar Z, et al. (2009) Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. (vol 284, pg 7385, 2009). Journal of Biological Chemistry 284(31):21100-21100. 76. Lee H, Goetzl EJ, & An SZ (2000) Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. American Journal of Physiology-Cell Physiology 278(3):C612-C618. 77. Pilquil C, et al. (2006) Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D-2-dependent phosphatidate generation. Journal of Biological Chemistry 281(50):38418-38429. 78. Goetzl EJ, Kong Y, & Voice JK (2000) Cutting edge: Differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. Journal of Immunology 164(10):4996-4999. 79. Rubenfeld J, et al. (2006) Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 290(1):L66-L74. 80. Chen RB, et al. (2006) Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells. Stem Cells and Development 15(6):797-804. 81. Panther E, et al. (2002) The influence of lysophosphatidic acid on the functions of human dendritic cells. Journal of Immunology 169(8):4129-4135. 82. Kanda H, et al. (2008) Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nature Immunology 9(4):415-423. 83. Dealvarez RR & Goodell BW (1964) SERUM LIPID PARTITIONS + FATTY ACID COMPOSITION ( USING GAS CHROMATOGRAPHY ) IN GYNECOLOGICAL CANCER. American Journal of Obstetrics and Gynecology 88(8):1039-&. 84. Tokumura A, et al. (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. Journal of Biological Chemistry 277(42):39436-39442. 85. Umezu-Goto M, et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. Journal of Cell Biology 158(2):227-233. 86. Hope JM, et al. (2009) LPA receptor 2 mediates LPA-induced endometrial cancer invasion. Gynecologic Oncology 112(1):215-223. 87. Kim KS, et al. (2006) Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Research 66(16):7983-7990. 88. Budnik LT & Mukhopadhyay AK (2002) Lysophosphatidic acid and its role in reproduction. Biology of Reproduction 66(4):859-865. 89. Tokumura A, et al. (2002) Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biology of Reproduction 67(5):1386-1392. 90. Ye XQ, Skinner MK, Kennedy G, & Chun J (2008) Age-dependent loss of sperm production in mice via impaired tysophosphatidic acid signaling. Biology of Reproduction 79(2):328-336. 38 91. Mohamed OA, et al. (2005) Uterine Wnt/beta-catenin signaling is required for implantation. Proceedings of the National Academy of Sciences of the United States of America 102(24):8579-8584. 92. Song H, et al. (2002) Cytosolic phospholipase A(2)alpha is crucial for 'on-time' embryo implantation that directs subsequent development (vol 129, pg 2879, 2002). Development 129(15):3761-3761. 93. Ohuchi H, et al. (2008) Expression Patterns of the Lysophospholipid Receptor Genes During Mouse Early Development. Developmental Dynamics 237(11):3280-3294. 94. Ishii S, Noguchi K, & Yanagida K (2009) Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins & Other Lipid Mediators 89(3-4):57-65. 95. Dottori M, Leung J, Turnley AM, & Pebay A (2008) Lysophosphatidic acid inhibits neuronal differentiation of neural stem/progenitor cells derived from human embryonic stem cells. Stem Cells 26(5):1146-1154. 96. Haseruck N, et al. (2004) The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y(1) and P2Y(12) receptors. Blood 103(7):2585-2592. 97. Siess W, et al. (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 96(12):6931-6936. 98. Akkerman JWN (2008) From low-density lipoprotein to platelet activation. International Journal of Biochemistry & Cell Biology 40(11):2374-2378. 99. Khandoga AL, et al. (2008) Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin. Platelets 19(6):415-427. 100. Pamuklar Z, et al. (2008) Individual heterogeneity in platelet response to lysophosphatidic acid - Evidence for a novel inhibitory pathway. Arteriosclerosis Thrombosis and Vascular Biology 28(3):555-561. 101. Liu YB, et al. (2010) LPA Induces Osteoblast Differentiation Through Interplay of Two Receptors: LPA1 and LPA4. Journal of Cellular Biochemistry 109(4):794-800. 102. Murakami M, Shiraishi A, Tabata K, & Fujita N (2008) Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. Biochemical and Biophysical Research Communications 371(4):707-712. 103. Tabata KI, Baba K, Shiraishi A, Ito M, & Fujita N (2007) The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochemical and Biophysical Research Communications 363:861-866. 104. Lee SJ, et al. (2008) LPA(1) is essential for lymphatic vessel development in zebrafish. Faseb Journal 22(10):3706-3715. 105. Kalen M, et al. (2009) Combination of Reverse and Chemical Genetic Screens Reveals Angiogenesis Inhibitors and Targets. Chemistry & Biology 16(4):432-441. 106. Thisse C & Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nature Protocols 3(1):59-69. 107. Li G, Mosier PD, Fang XJ, & Zhang Y (2009) Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: A homology modeling study. Journal of Molecular Graphics & Modelling 28(1):70-79. 108. Woods IG, et al. (2005) The zebrafish gene map defines ancestral vertebrate chromosomes. Genome Research 15(9):1307-1314. 109. Bjarnadottir TK, et al. (2006) Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88(3):263-273. 39 110. Bockaert J & Pin JP (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. Embo Journal 18(7) | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10474 | - |
dc.description.abstract | 水解磷酸酯為一種結構簡單的酯質卻同時調控多種生理功能,包括細胞增生、移動、分化、以及胚胎發育。目前已知之水解磷酸酯受器有五種,其中水解磷酸酯受器一至三屬於內皮細胞分化基因群,而水解磷酸酯受器四至五則屬於另一嘌呤受器基因群。在斑馬魚系統中,水解磷酸酯受器一已知會調控淋巴管發育,而水解磷酸酯受器三則負責神經管發育。此研究中,我們經由TBLASTN演算法比對斑馬魚與小鼠之基因序列,而取得斑馬魚水解磷酸酯受器四與五之序列。將斑馬魚水解磷酸酯受器四與五和所有已知之水解磷酸酯受器與嘌呤受器基因群綜合比對之後,斑馬魚水解磷酸酯受器四與五分別歸屬於水解磷酸酯受器四與五之基因群。斑馬魚水解磷酸酯受器四表現在五天大之魚鰓、睪丸以及脾臟等處。斑馬魚水解磷酸酯受器五則在十八體節發育期之後在全身表現。斑馬魚水解磷酸酯受器四與五異位表現在大鼠細胞株B103中無法接受水解磷酸酯調控細胞內鈣離子濃度。然而在斑馬魚胚胎中降低斑馬魚水解磷酸酯受器四之表現卻明顯的抑制斑馬魚之血管發育,導致胚胎嚴重水腫。綜合以上實驗,斑馬魚水解磷酸酯受器四應為調控斑馬魚循環發育之重要基因。 | zh_TW |
dc.description.abstract | Lysophosphatidic acid (LPA) is a simple lysophospholipid which regulates various important biological functions such as cell proliferation, migration, differentiation, and morphogenesis. The LPA receptor on cell membrane has been identified and, designated as LPA1-5. LPA1-3 are the major members of the endothelial differentiation gene (EDG) family. LPA4-5, structurally distinct from LPA1-3, were first discovered as purinergic receptors in P2Y family. In zebrafish (Danio rerio), LPA1 and LPA3 have been identified essential for neural tube and lymphatic vessel development, while the function of other LPA receptors are not yet identified. We searched LPA receptors using the TBLASTN algorithm in the zebrafish nucleotide database, and found zLPA4 and one sequence similar to both LPA5 and P2Y5 in mice. After aligning all the known LPA receptors, the sequence showed more similarities with LPA5 than with P2Y5. In zebrafish, zLPA4 is expressed in the gills, testis and spleen after 5 dpf, and zLPA5 is expressed in most tissues after the 18 somites stage. LPA induced Ca++ mobilization in zLPA4 or zLPA5 over-expressed B103 rat neuroblastoma was not observed. This indicates that zebrafish LPA receptors might not trigger the conventional cascade of mammalian LPA receptors. However, down-regulation of zLPA4 leads to defections in vascular development, which needs more evidence to clarify. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T21:32:25Z (GMT). No. of bitstreams: 1 ntu-99-R97b41031-1.pdf: 1271947 bytes, checksum: 7374984562e9b9c4ec016b068cfb801d (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | Introduction ......................................................................................................................... 1
Metabolism .............................................................................................................. 3 EDG family LPA receptors ...................................................................................... 6 Discovering the “non-Edg” LPA receptor LPAR4 .................................................... 9 LPA5 ...................................................................................................................... 10 Biological functions of LPA ................................................................................... 11 Nervous system ..................................................................................................... 12 Vascular system ..................................................................................................... 12 Immune system ..................................................................................................... 13 Cancer.................................................................................................................... 13 Reproduction ......................................................................................................... 14 Gene expression and physiological function of LPA4 and LPA5 ............................. 14 Expression ............................................................................................................. 15 Reproduction ......................................................................................................... 15 Neural physiology .................................................................................................. 16 Platelets ................................................................................................................. 16 VII Interconnected mutual regulation ........................................................................... 17 Zebrafish as a model for LPA receptor research ..................................................... 18 Material and Methods ............................................................................................................ 20 Protein sequence alignment .................................................................................... 20 Phylogenetic tree and percentage similarity analysis .............................................. 20 Expression construct of zLPA4 and zLPA5 ............................................................. 20 Stage and Tissue dependent RNA expression ......................................................... 21 Whole mount in situ hybridization ......................................................................... 22 LPA induced Ca++ mobilization ............................................................................ 24 Bone and cartilage differential staining .................................................................. 24 Results ................................................................................................................................. 25 Hierarchical tree of all known LPA, S1P, P2RY receptors ..................................... 25 Protein sequence alignment of human, mouse and zebrafish LPA4 and LPA5 ......... 25 Percentage similarity of LPA4 and LPA5 between species ...................................... 26 LPA induced calcium mobilization in B103 cells through zLPA4 and zLPA5 ......... 26 Developmental stage dependent zLPA4 and zLPA5 RNA expression ...................... 27 Whole mount in situ hybridization of zLPA4 and zLPA5 ........................................ 27 VIII Discussion ............................................................................................................................. 28 Reference .............................................................................................................................. 33 Figures ................................................................................................................................. 40 | |
dc.language.iso | en | |
dc.title | 斑馬魚水解磷酸酯受器4與5之研究 | zh_TW |
dc.title | Identification of Zebrafish LPA Receptor 4 and 5 | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳俊宏(Jiun-Hong Chen),黃偉邦(Wei-Pang Huan),張百恩(Bei-En CHANG) | |
dc.subject.keyword | 水解磷酸酯,水解磷酸酯受器,斑馬魚,血管,發育, | zh_TW |
dc.subject.keyword | Lysophosphatidic acid,Lysophosphatidic acid receptor,blood vessel,zebrafish,development, | en |
dc.relation.page | 46 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2010-08-18 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 動物學研究所 | zh_TW |
顯示於系所單位: | 動物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf | 1.24 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。